Case Studies
Hemp THC Ban Moves Closer as Congressional Fixes Collapse
WASHINGTON – The federal clock on hemp-derived THC products is ...
RYTHM Reports Q4 and FY 2025 Financial Results
ROLLING MEADOWS – RYTHM Inc. delivered a significant revenue leap ...
California Collected $255M in Q4 Cannabis Tax Revenue
SACRAMENTO – California collected $255.1 million in Cannabis tax revenue ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
Arkansas Medical Cannabis Sales Are Expected to Break Previous Record
LITTLE ROCK – Dispensaries in Arkansas have recorded $193.1 million in medical Cannabis sales from January through August, according to data from the state Department of Finance and Administration. This figure positions the market to ...
Rhode Island Launched Applications for Additional Cannabis Retail Licenses
PROVIDENCE – The Rhode Island Cannabis Control Commission has started taking applications for 24 additional adult-use Cannabis retail licenses, a step that expands the state's recreational market three years after legalization. The licenses are spread ...
Week In Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Wrapping up the first half of September 2025, it's worth noting that the Cannabis & Psychedelics industries continue proving their resilience amid political uncertainty and turbulent market dynamics. From stock rallies signaling ...
Former Arizona Senator Sinema Advocates Ibogaine Research Post-Treatment
LOS ANGELES – Former U.S. Senator Kyrsten Sinema of Arizona shared details of her personal encounter with ibogaine during a recent appearance on CNN. Speaking with Jake Tapper, Sinema highlighted her push for expanded research into ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
